[go: up one dir, main page]

NO934011D0 - Genmanipulasjon og ekspresjon ved bruk av genomiske elementer - Google Patents

Genmanipulasjon og ekspresjon ved bruk av genomiske elementer

Info

Publication number
NO934011D0
NO934011D0 NO1993934011A NO934011A NO934011D0 NO 934011 D0 NO934011 D0 NO 934011D0 NO 1993934011 A NO1993934011 A NO 1993934011A NO 934011 A NO934011 A NO 934011A NO 934011 D0 NO934011 D0 NO 934011D0
Authority
NO
Norway
Prior art keywords
mammalian
gene
expression
fragment
homologous recombination
Prior art date
Application number
NO1993934011A
Other languages
English (en)
Other versions
NO934011L (no
Inventor
Stephen Sherwin
Sue Klapholz
Arthur Skoultchi
Original Assignee
Cell Genesys Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24796175&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO934011(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cell Genesys Inc filed Critical Cell Genesys Inc
Publication of NO934011D0 publication Critical patent/NO934011D0/no
Publication of NO934011L publication Critical patent/NO934011L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/20—Pseudochromosomes, minichrosomosomes
    • C12N2800/206—Pseudochromosomes, minichrosomosomes of yeast origin, e.g. YAC, 2u
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/44—Vectors comprising a special translation-regulating system being a specific part of the splice mechanism, e.g. donor, acceptor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Reproductive Health (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO934011A 1991-05-06 1993-11-05 Genmanipulasjon og ekspresjon ved bruk av genomiske elementer NO934011L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69621691A 1991-05-06 1991-05-06
PCT/US1992/003686 WO1992019255A1 (en) 1991-05-06 1992-05-05 Gene manipulation and expression using genomic elements

Publications (2)

Publication Number Publication Date
NO934011D0 true NO934011D0 (no) 1993-11-05
NO934011L NO934011L (no) 1994-01-05

Family

ID=24796175

Family Applications (1)

Application Number Title Priority Date Filing Date
NO934011A NO934011L (no) 1991-05-06 1993-11-05 Genmanipulasjon og ekspresjon ved bruk av genomiske elementer

Country Status (10)

Country Link
EP (1) EP0584214B1 (no)
JP (2) JPH06507550A (no)
KR (1) KR100259933B1 (no)
AT (1) ATE272121T1 (no)
AU (1) AU671801B2 (no)
CA (2) CA2102594C (no)
DE (1) DE69233387T2 (no)
NO (1) NO934011L (no)
SG (1) SG93780A1 (no)
WO (1) WO1992019255A1 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6048729A (en) * 1987-05-01 2000-04-11 Transkaryotic Therapies, Inc. In vivo protein production and delivery system for gene therapy
PT101031B (pt) 1991-11-05 2002-07-31 Transkaryotic Therapies Inc Processo para o fornecimento de proteinas por terapia genetica
US6054288A (en) * 1991-11-05 2000-04-25 Transkaryotic Therapies, Inc. In vivo protein production and delivery system for gene therapy
US5968502A (en) * 1991-11-05 1999-10-19 Transkaryotic Therapies, Inc. Protein production and protein delivery
US6063630A (en) * 1991-11-05 2000-05-16 Transkaryotic Therapies, Inc. Targeted introduction of DNA into primary or secondary cells and their use for gene therapy
US6692737B1 (en) 1991-11-05 2004-02-17 Transkaryotic Therapies, Inc. In vivo protein production and delivery system for gene therapy
US5641670A (en) * 1991-11-05 1997-06-24 Transkaryotic Therapies, Inc. Protein production and protein delivery
US6670178B1 (en) 1992-07-10 2003-12-30 Transkaryotic Therapies, Inc. In Vivo production and delivery of insulinotropin for gene therapy
US6531124B1 (en) 1992-07-10 2003-03-11 Transkaryotic Therapies, Inc. In vivo production and delivery of insulinotropin for gene therapy
EP0742285A1 (en) * 1995-05-10 1996-11-13 Rijksuniversiteit Leiden Method of isolating exonic gene segments of eukaryotic genes, exon trapping vectors for use therein
US6897066B1 (en) 1997-09-26 2005-05-24 Athersys, Inc. Compositions and methods for non-targeted activation of endogenous genes
US6740503B1 (en) 1997-09-26 2004-05-25 Athersys, Inc. Compositions and methods for non-targeted activation of endogenous genes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4656134A (en) * 1982-01-11 1987-04-07 Board Of Trustees Of Leland Stanford Jr. University Gene amplification in eukaryotic cells
US4740461A (en) * 1983-12-27 1988-04-26 Genetics Institute, Inc. Vectors and methods for transformation of eucaryotic cells
US4889806A (en) * 1987-04-15 1989-12-26 Washington University Large DNA cloning system based on yeast artificial chromosomes
ES2127458T3 (es) * 1989-11-06 1999-04-16 Cell Genesys Inc Produccion de proteinas utilizando recombinacion homologa.
RU2128227C1 (ru) * 1989-12-22 1999-03-27 Апплайд Резеч Системз АРС Холдинг Н.В. (NL) (Антильские острова) Способ активации транскрипционно-молчащего гена

Also Published As

Publication number Publication date
WO1992019255A1 (en) 1992-11-12
EP0584214A4 (en) 1995-04-19
ATE272121T1 (de) 2004-08-15
DE69233387D1 (de) 2004-09-02
CA2102628A1 (en) 1992-11-07
CA2102594A1 (en) 1992-11-07
EP0584214B1 (en) 2004-07-28
JP2008086326A (ja) 2008-04-17
EP0584214A1 (en) 1994-03-02
AU671801B2 (en) 1996-09-12
CA2102594C (en) 2007-07-17
NO934011L (no) 1994-01-05
SG93780A1 (en) 2003-01-21
DE69233387T2 (de) 2005-07-21
KR100259933B1 (ko) 2000-06-15
JPH06507550A (ja) 1994-09-01
AU1973292A (en) 1992-12-21

Similar Documents

Publication Publication Date Title
Wasels et al. A two-plasmid inducible CRISPR/Cas9 genome editing tool for Clostridium acetobutylicum
US10301613B2 (en) Targeted remodeling of prokaryotic genomes using CRISPR-nickases
Smedley et al. CRISPR‐Cas9 based genome editing in wheat
CY1122059T1 (el) Μεθοδος τροποποιησης ευκαρυωτικων κυτταρων
NO934011D0 (no) Genmanipulasjon og ekspresjon ved bruk av genomiske elementer
NO20031897L (no) Fremgangsmåte for modifisering av eukaryotiske celler
DK0770136T3 (da) Fremgangsmåde til at selektere höjtudtrykkende værtsceller
EP0945515A3 (en) Production of proteins using homologous recombination
Yuan et al. A marker-free system for highly efficient construction of vaccinia virus vectors using CRISPR Cas9
CA3000170A1 (en) Antiviral methods and compositions
Mielich et al. Maize transposable elements Ac/Ds as insertion mutagenesis tools in Candida albicans
BR9610738A (pt) Integração aperfeiçoada de dna exógeno transferido para as células eucarióticas
Giersch et al. Yeast still a beast: diverse applications of CRISPR/Cas editing technology in S. cerevisiae
RU2002113373A (ru) 9α-γидроксилирование стероидов микроорганизмами
FR2784394B1 (fr) Cassette d'integration-excision
Kramerov et al. Structure and origin of a novel dimeric retroposon B1-diD
CN105238820A (zh) 一种用于大肠杆菌基因敲入的负筛选标记
CN116064643B (zh) 一种提高双子叶植物单碱基编辑器编辑效率的方法及其应用
Kozgunova tRNA-Based Polycistronic CRISPR/Cas9 System Boosts Efficiency of Multi-Gene Deletion in the Moss Physcomitrella
CN119144637A (zh) 热葡糖苷酶地芽孢杆菌CRISPR type I-B基因编辑及其应用
CN116042715A (zh) 一种鸡tdrd1基因启动子区域组蛋白甲基化水平的调控方法
Hermanson et al. Rescuing YAC‐Insert Ends as E. coli Plasmids
Egner EXCISION AND TRANSPOSITION OF TN5 AND OTHER TRANSPOSONS.
Kovach Somatic cell genetics of mosquito cells.